日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment

IL-19作为一种有前景的诊疗靶点，可用于重编程胶质母细胞瘤的免疫抑制微环境

期刊:Journal of Biomedical Science
影响因子:9
doi:10.1186/s12929-025-01126-w
Gilbert Aaron Lee ,Justin Bo-Kai Hsu ,Yu-Wei Chang ,Li-Chun Hsieh ,Yi-Tien Li ,Ying Chieh Wu ,Cheng-Ying Chu ,Yung-Hsiao Chiang ,Wan-Yuo Guo ,Chih-Chun Wu ,Liang-Wei Chen ,Hung-Wen Kao ,Wan-Li Lin ,Li-Wen Tseng ,Ting-Wei Weng ,Duen-Pang Kuo ,Sho-Jen Cheng ,Yung-Chieh Chen ,Shiu-Wen Huang ,Hsing-Jien Kung ,Cheng-Yu Chen
IL-19
免疫/内分泌
细胞生物学
发表日期：2025
文献求助 收藏

Prognostic value of three clinical nutrition scoring system (NRI, PNI, and CONUT) in elderly patients with prostate cancer

三种临床营养评分系统（NRI、PNI 和 CONUT）对老年前列腺癌患者的预后价值

期刊:Frontiers in Nutrition
影响因子:5.1
doi:10.3389/fnut.2024.1436063
Li, Shu-Ying; Wan, Li-Lin; Liu, Yi-Fan; Li, Yu-Wei; Huang, Xiang; Liu, Rui-Ji
肿瘤
前列腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy

驱动基因突变对接受新辅助免疫治疗和化疗的早期肺癌患者治疗结果的影响

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-022-07423-w
Su, Po-Lan; Chen, Jung-Yueh; Chu, Chang-Yao; Chen, Yi-Lin; Chen, Wan-Li; Lin, Kuan-Yu; Ho, Chung-Liang; Tsai, Jeng-Shiuan; Yang, Szu-Chun; Chen, Chian-Wei; Wu, Yi-Lin; Tseng, Yau-Lin; Chang, Chao-Chun; Yen, Yi-Ting; Lin, Chia-Ying; Lin, Chien-Chung; Su, Wu-Chou
肺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2022
文献求助 收藏

Myeloid Neoplasm with PCM1-PDGFRB Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review

PCM1-PDGFRB转录本阳性的髓系肿瘤对低剂量伊马替尼治疗有效：一例病例报告及文献复习

期刊:Acta Haematologica
影响因子:1.1
doi:10.1159/000524275
Wang, Zhe; Wan, Li; Lin, Dong; Li, Cheng-Wen; Tian, Zheng; Mi, Ying-Chang
PCM1
PDGFRB
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid‑Coated Superparamagnetic Iron Oxide

使用与脂质包被的超顺磁性氧化铁结合的 PD-L1 抗体检测替莫唑胺耐药胶质母细胞瘤中的 PD-L1 表达

期刊:International Journal of Nanomedicine
影响因子:6.6
doi:10.2147/IJN.S310464
Gilbert Aaron Lee, Wan-Li Lin, Duen-Pang Kuo, Yi-Tien Li, Yu-Wei Chang, Yung-Chieh Chen, Shiu-Wen Huang, Justin Bo-Kai Hsu, Cheng-Yu Chen
细胞生物学
肿瘤
胶质瘤
其它细胞
发表日期：2021
文献求助 收藏

Durable Response to Combined Dabrafenib and Trametinib in a Patient With BRAF K601E Mutation-Positive Lung Adenocarcinoma: A Case Report

一例BRAF K601E突变阳性肺腺癌患者接受达拉非尼联合曲美替尼治疗后获得持久疗效：病例报告

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2021.100202
Su, Po-Lan; Lin, Chien-Yu; Chen, Yi-Lin; Chen, Wan-Li; Lin, Chien-Chung; Su, Wu-Chou
肿瘤
BRAF
肿瘤免疫
发表日期：2021
文献求助 收藏

Thyroid hormone receptor-mediated regulation of the methionine adenosyltransferase 1 gene is associated with cell invasion in hepatoma cell lines.

甲状腺激素受体介导的甲硫氨酸腺苷转移酶 1 基因的调控与肝癌细胞系的细胞侵袭有关

期刊:Cellular and Molecular Life Sciences
影响因子:6.2
doi:10.1007/s00018-010-0281-2
Wu Sheng-Ming, Huang Ya-Hui, Lu Yi-Hsin, Chien Ling-Fang, Yeh Chau-Ting, Tsai Ming-Ming, Liao Chen-Hsin, Chen Wei-Jan, Liao Chia-Jung, Cheng Wan-Li, Lin Kwang-Huei
细胞生物学
肝癌
肿瘤免疫
发表日期：2010
文献求助 收藏